Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Azimilide

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Azimilide?

Azimilide is an investigational drug.

There have been 8 clinical trials for Azimilide. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2000.

The most common disease conditions in clinical trials are Atrial Fibrillation, Heart Diseases, and Emergencies. The leading clinical trial sponsors are Forest Laboratories, Warner Chilcott, and [disabled in preview].

Recent Clinical Trials for Azimilide
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)Forest LaboratoriesPhase 3
Effect of Azimilide Dihydrochloride on Renal FunctionWarner ChilcottPhase 1
Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One PatientWarner ChilcottPhase 2

See all Azimilide clinical trials

Clinical Trial Summary for Azimilide

Top disease conditions for Azimilide
Top clinical trial sponsors for Azimilide

See all Azimilide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.